PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative and practical articles on the application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes. An invaluable source of applied pharmacoeconomic original research and educational material for the healthcare decision maker.

PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to patient care and drug utilization.

PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article.

《药物经济学》是同行评审的权威实用文章的标杆期刊，文章内容涉及药物经济学和生活质量评估在最佳药物治疗和健康结果中的应用。它是医疗决策者获取应用药物经济学原创研究和教育材料的宝贵来源。

《药物经济学》致力于清晰地传达与患者护理和药物使用相关的复杂药物经济学问题。

《药物经济学》提供了一系列附加功能，旨在提高期刊内容的可见性、读者群和教育价值。每篇文章都附有要点摘要，为广大读者提供内容的省时概述。文章可能附有通俗易懂的摘要，以帮助对该领域有一定了解但不具备深入专业知识的读者了解文章的科学内容和总体含义。

该刊已被国际权威数据库SCIE、SSCI收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-药学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为4.4，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。